Erratum to: Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria: Growth Hormone and Podocytes (Journal of Cellular Biochemistry, (2015), 116, 9, (1947-1956), 10.1002/jcb.25150);Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria

Journal of Cellular Biochemistry

Volumn 116, Issue 9, 2015, Pages 1947-1956

  Swathi Chitra, P ^a   Swathi, T ^a   Sahay, Rakesh ^b   Reddy, G Bhanuprakash ^a   Menon, Ram K ^c   Kumar, P Anil ^d  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b OSMANIA GENERAL HOSPITAL   (India)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF HYDERABAD   (India)

Author keywords

E cadherin; growth hormone; podocytes; TGFBIp; ZEB2

Indexed keywords

ALBUMIN; BETA CATENIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; NERVE CELL ADHESION MOLECULE; PROTEIN ZEB2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; TUBULIN; UNCLASSIFIED DRUG; UVOMORULIN; BETAIG-H3 PROTEIN; SCLEROPROTEIN; SERUM ALBUMIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PERMEABILIZATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION; MICROARRAY ANALYSIS; MONOLAYER CULTURE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PODOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEINURIA; ANIMAL; CELL LINE; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RAT; UPREGULATION; WISTAR RAT;

RATTUS;

ANIMALS; APOPTOSIS; CELL LINE; CELL MOVEMENT; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GROWTH HORMONE; HUMANS; MICE; PODOCYTES; RATS; RATS, WISTAR; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84937469512     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.29340     Document Type: Erratum

References (37)

1. Aaltonen P, Luimula P, Astrom E, Palmen T, Gronholm T, Palojoki E, Jaakkola I, Ahola H, Tikkanen I, Holthofer H,. 2001. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81: 1185-1190.
2. Anil Kumar P, Welsh GI, Saleem MA, Menon RK,. 2014. Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus. Front Endocrinol (Lausanne) 5: 151.
3. Bae JS, Lee SH, Kim JE, Choi JY, Park RW, Yong Park, Sohn HS, Lee YS, Bae DS, Lee, Kim E,. 2002. Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun 294: 940-948.
4. Baldelli R, De Marinis L, Bianchi A, Pivonello R, Gasco V, Auriemma R, Pasimeni G, Cimino V, Appetecchia M, Maccario M, Lombardi G, Pontecorvi A, Colao A, Grottoli S,. 2008. Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 93: 710-714.
5. Christiansen JS, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving HH,. 1981. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11: 487-490.
6. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D,. 1998. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 47: 1341-1346.
7. Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, Striker GE,. 1990. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 137: 541-552.
8. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP,. 1990. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71: 1356-1362.
9. El Nahas, Cope AH, Le Carpentier GH,. 1991. Role of growth hormone in the development of experimental renal scarring. Kidney Int 40: 29-34.
10. Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, Kelly DJ, Jerums G, Pollock CA, Cooper ME,. 1998. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int 54: 1052-1062.
11. Han JH, Ha SW, Lee IK, Kim BW, Kim JG,. 2010. High glucose-induced apoptosis in bovine retinal pericytes is associated with transforming growth factor beta and betaIG- H3: betaIG-H3 induces apoptosis in retinal pericytes by releasing Arg-Gly-Asp peptides. Clin Experiment Ophthalmol 38: 620-628.
12. Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, Tiwari S,. 2013. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS ONE 8: e60177.
13. Kannabiran C, Klintworth GK,. 2006. TGFBI gene mutations in corneal dystrophies. Hum Mutat 27: 615-625.
14. Kim JE, Kim SJ, Jeong HW, Lee BH, Choi JY, Park RW, Park JY, Kim IS,. 2003a. RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene 22: 2045-2053.
15. Kim MO, Yun SJ, Kim IS, Sohn S, Lee EH,. 2003b. Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin. Neurosci Lett 336: 93-96.
16. Kolset SO, Reinholt FP, Jenssen T,. 2012. Diabetic nephropathy and extracellular matrix. J Histochem Cytochem 60: 976-986.
17. Kumar PA, Brosius FC, Menon 3rd,. 2011. The glomerular podocyte as a target of growth hormone action: Implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev 7: 50-55.
18. Kumar PA, Chitra PS, Reddy GB,. 2013. Metabolic syndrome and associated chronic kidney diseases: Nutritional interventions. Rev Endocr Metab Disord 14: 273-286.
19. Kumar PA, Kotlyarevska K, Dejkhmaron P, Reddy GR, Lu C, Bhojani MS, Menon RK,. 2010. Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: A novel action of gh with implications for the pathogenesis of diabetic nephropathy. J Biol Chem 285: 31148-31156.
20. Landau D, Israel E, Rivkis I, Kachko L, Schrijvers BF, Flyvbjerg A, Phillip M, Segev Y,. 2003. The effect of growth hormone on the development of diabetic kidney disease in rats. Nephrol Dial Transplant 18: 694-702.
21. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y,. 2008. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308.
22. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ, Wang XF,. 2008. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22: 308-321.
23. Manelli F, Bossoni S, Burattin A, Doga M, Solerte SB, Romanelli G, Giustina A,. 2000. Exercise-induced microalbuminuria in patients with active acromegaly: Acute effects of slow-release lanreotide, a long-acting somatostatin analog. Metabolism 49: 634-639.
24. Mason RM, Wahab NA,. 2003. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373.
25. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H,. 2000. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15: 1379-1383.
26. Nummela P, Lammi J, Soikkeli J, Saksela O, Laakkonen P, Holtta E,. 2012. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells. Am J Pathol 180: 1663-1674.
27. Reddy GR, Pushpanathan MJ, Ransom RF, Holzman LB, Brosius FC, Diakonova 3rd, Mathieson M, Saleem P, List MA, Kopchick EO, Frank JJ, Menon SJ,. 2007. Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology 148: 2045-2055.
28. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC,. 2009. Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20: 1041-1052.
29. Shankland SJ,. 2006. The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147.
30. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF,. 1992. CDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 11: 511-522.
31. Thapa N, Kang KB, Kim IS,. 2005. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone 36: 232-242.
32. Tonshoff B, Veldhuis JD, Heinrich U, Mehls O,. 1995. Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res 37: 86-93.
33. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, Giannoni M, Rimoldi L, Lauria F, Miji M, Deferrari G, Garibotto G,. 2007. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72: 1262-1272.
34. Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK,. 2011. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer 128: 1570-1584.
35. Ween MP, Oehler MK, Ricciardelli C,. 2012. Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(betaig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer. Int J Mol Sci 13: 10461-10477.
36. Wolf G, Chen S, Ziyadeh FN,. 2005. From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634.
37. Zamilpa R, Rupaimoole R, Phelix CF, Somaraki-Cormier M, Haskins W, Asmis R, LeBaron RG,. 2009. C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells. Matrix Biol 28: 347-353.